US seniors' multiple Rxs studied
34% of US seniors are taking medications prescribed by two or morephysicians and 72% are taking medications first prescribed for them more than six months ago, according to a new survey conducted for the American Society of Health-System Pharmacists.
76% of the 275 Americans aged 65 and older questioned for the study said they were taking at least three medications, and 33% take eight or more. Among this group, 53% said they were taking three or more prescription medications. These findings are similar to those of a study by RxHealthValue (Marketletter August 13).
In general, seniors are concerned about both side effects and drug interactions, the study found. Respondents were more likely to look for information about drug interactions for new prescription medications (62%) than for nonprescription products (47%).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze